WASHINGTON, D.C. – U.S. Senator Tammy Baldwin of Wisconsin last week co-sponsored a bipartisan amendment to the National Defense Authorization Act (NDAA) that would prevent additional regulations and red tape from being added to the Defense Department’s medical research program.
Since 1992, Congress has provided more than $11.7 billion to researchers in universities, businesses, and laboratories all across the country to conduct life-saving research on numerous diseases and conditions that impact military members, veterans, and their families. However, provisions included in the National Defense Authorization Act (NDAA) would strangle the Department of Defense’s (DOD) Congressionally-Directed Medical Research Program (CDMRP) with red tape that would slow or halt research aimed at combating diseases and conditions that affect service members and their families, including traumatic brain injuries and post-traumatic stress. The Baldwin-supported provision would nullify the red tape provisions and allow the DOD’s medical research program to continue conducting life-saving research.
“Our service members, military families and veterans are facing the difficult challenges of physical injuries, disease, addiction, PTSD, and mental illnesses,” said Senator Baldwin. “The Department of Defense’s Congressionally-Directed Medical Research Program has conducted life-saving medical research specifically aimed at combating diseases and conditions that impact our service members and their families. This bipartisan provision would ensure that this important research is conducted free of red tape that would jeopardize the health of military families and veterans.”
In Wisconsin, Congressionally-Directed Medical Research includes work on traumatic brain injury, wound care and treatment, breast cancer and prostate cancer. Between 2011 and 2014, researchers in Wisconsin have received 26 awards totaling over $21 million.